Literature DB >> 1333182

Neurologic manifestations of progressive systemic sclerosis.

L Averbuch-Heller1, I Steiner, O Abramsky.   

Abstract

Neurologic involvement in progressive systemic sclerosis is considered uncommon. We retrospectively examined the prevalence and nature of neurologic complications in 50 patients with progressive systemic sclerosis. In 20 (40%), neurologic abnormalities were detected, with a total of 28 neurologic manifestations. All levels of the central and peripheral nervous system were affected: muscle (22%), peripheral nerve (18%), spinal cord (8%), and brain (6%). Of note were the presence of myelopathy in four patients and inclusion-body myositis in two. In 10 patients (20%), no definable cause of the neurologic dysfunction could be identified, apart from progressive systemic sclerosis. Thus, neurologic presentations of progressive systemic sclerosis are much more common than previously reported and may be due to direct involvement of the nervous system by a primary pathologic process in a significant number of patients.

Entities:  

Mesh:

Year:  1992        PMID: 1333182     DOI: 10.1001/archneur.1992.00530360094024

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

Review 1.  Peripheral neuropathy: clinical and electrophysiological considerations.

Authors:  Tae Chung; Kalpana Prasad; Thomas E Lloyd
Journal:  Neuroimaging Clin N Am       Date:  2013-05-25       Impact factor: 2.264

2.  Non-atherosclerotic vascular disease in the young.

Authors:  Osvaldo Camilo; Larry B Goldstein
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

3.  [Neurological manifestations in connective tissue disease].

Authors:  L Harms; F Hiepe
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

4.  Seizures in systemic sclerosis.

Authors:  Fernando Glasner Araújo; Tiago Nardi Amaral; Simone Appenzeller; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

5.  Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.

Authors:  Julie J Paik; Fredrick M Wigley; Thomas E Lloyd; Andrea M Corse; Livia Casciola-Rosen; Ami A Shah; Francesco Boin; Laura K Hummers; Andrew L Mammen
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

6.  Systemic sclerosis associated with generalized vasculitis and hypopituitarism.

Authors:  John C Katsantonis; John Protopsaltis; Stelios Kokkoris; Paris Brestas; Kyriaki Aroni; Symeon Tournis; Gregory Giannoulis
Journal:  Rheumatol Int       Date:  2008-04-24       Impact factor: 2.631

7.  Systemic sclerosis and superficial siderosis of the central nervous system: casuality or causality?

Authors:  Sara Simeoni; Antonio Puccetti; Elisa Tinazzi; Giuliano Tomelleri; Roberto Corrocher; Claudio Lunardi
Journal:  Rheumatol Int       Date:  2008-01-12       Impact factor: 2.631

Review 8.  Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Authors:  Ulrich A Walker; Philip J Clements; Yannick Allanore; Oliver Distler; Chester V Oddis; Dinesh Khanna; Daniel E Furst
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

Review 9.  Acute cerebral vasculopathy in systemic sclerosis.

Authors:  Benoit Faucher; Brigitte Granel; Francois Nicoli
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

10.  Electrophysiological evidence of "nerve entrapment syndromes" and subclinical peripheral neuropathy in progressive systemic sclerosis (scleroderma).

Authors:  M Mondelli; C Romano; P D Della Porta; A Rossi
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.